The Food and Drug Administration has launched a new safety review of the abortion pill mifepristone, according to reports.
The medication has been available on the market for over 25 years, the Independent UK reported. According to the outlet, roughly 7.5 million women have taken the pill over the past 25 years.
Pro-life advocates welcomed the FDA's decision to conduct the safety review, Newsmax reported. These advocates had been urging the Trump administration to take a close look at the drug, according to the outlet.
The safety review will examine whether mifepristone is safe, the Independent UK reported. The outlet noted that the FDA will study the drug despite its lengthy history on the market.
The FDA's action represents a new examination of mifepristone's safety profile. The drug has been the subject of ongoing regulatory debate.
The safety review was initiated as the Trump administration addresses issues related to abortion policy. Pro-life advocates had specifically called for additional scrutiny of mifepristone, Newsmax reported.
The FDA has not yet released details about the timeline or scope of the safety review. The review process will assess the safety record of mifepristone.
Read the original coverage
💬 Comments
📜 Comment Policy